Climate Change and Marine Natural Products
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (31 May 2020) | Viewed by 4491
Special Issue Editors
Interests: marine natural products chemistry; infectious diseases; cancer; spectroscopy; drug discovery and development
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Since the 1950s, a growing number of secondary metabolites have been characterized from marine invertebrates, plants, algae, and microbes, which has provided a vast array of structural diversity and potential drug leads. However, the diversity of the oceans and coral reef communities in general is challenged like no other as a product of climate change. At the same time, climate change is having a growing influence in the emergence of a variety of human health issues. Of course, the recent Nobel Prizes awarded to William Campbell, Satoshi Omura, and Tu Youyou for their pioneering work in the development of treatments for roundworm parasites and malaria emphasize the significance of natural product discoveries in the control of emerging diseases.
In this Special Issue of Marine Drugs, we are encouraging investigators to provide preliminary communications, expert opinions, research papers, and reviews covering the impact that climate change is having and will have on the future of emerging diseases, marine species diversity, drug discovery, and human health. In this compilation of papers, we will also assess the impact climate change is having on the marine environment, human health, and our ability of react with new chemical entities from the oceans. We would also encourage contributions that assess climate change and the impact climate change is having on both marine biodiversity as well as the global prevalence of emerging diseases.
Prof. Mark Hamann
Dr. Xiaoyan Chen
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- marine therapeutics and species diversity
- climate change and its impact on the oceans
- tropical neglected diseases
- drug discovery and development
- natural products synthesis
- methodologies in natural products discovery
- climate change and emerging diseases
